Skip to main content
Log in

Cushingoid lipodystrophy can be prevented by thiazolidinediones

  • Research Letter
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. C. Gazzaruso, An increased risk for fractures: another cause of frailty in HIV-infected subjects. Endocrine 41(3), 347–349 (2012)

    Article  PubMed  CAS  Google Scholar 

  2. M. Christ-Crain, B. Kola, F. Lolli, C. Fekete, D. Seboek, G. Wittmann, D. Feltrin, S.C. Igreja, S. Ajodha, J. Harvey-White, G. Kunos, B. Müller, F. Pralong, G. Aubert, G. Arnaldi, G. Giacchetti, M. Boscaro, A.B. Grossman, M. Korbonits, AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing’s syndrome. FASEB 22, 1672–1683 (2008)

    Article  CAS  Google Scholar 

  3. S. Leroyer et al., Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue. J. Lipid Res. 52, 207–220 (2011)

    Article  PubMed  CAS  Google Scholar 

  4. H. Yki-Javinen, Thiazolidinediones. N. Engl. J. Med. 351, 1106–1118 (2004)

    Article  Google Scholar 

  5. T. Cadoudal, J.M. Blouin, M. Collinet, F. Fouque, G.D. Tan, E. Loizon, E.G. Beale, K.N. Frayn, F. Karpe, H. Vidal, C. Benelli, C. Forest, Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes. Diabetologia 50(3), 666–675 (2007)

    Article  PubMed  CAS  Google Scholar 

  6. J.W. Tomlinson, E.A. Walker, I.J. Bujalska, N. Draper, G.G. Lavery, M.S. Cooper, M. Hewison, P.M. Stewart, 11 β Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response. Endocr. Rev. 25(5), 831–866 (2004)

    Article  PubMed  CAS  Google Scholar 

  7. J. Berger, M. Tanen, A. Elbrecht, Peroxisome proliferator-activated receptor-g ligands inhibit adipocyte 11 β-hydroxysteroid dehydrogenase type 1 expression and activity. J. Biol. Chem. 276(16), 12629–12635 (2001)

    Article  PubMed  CAS  Google Scholar 

  8. I. Karatsereos, S. Bhagat, Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse. Endocrinology 151(5), 2117–2127 (2010)

    Article  Google Scholar 

  9. A.J. Sanyal, N. Chalasani, K.V. Kowdley, A. McCullough, A.M. Diehl, N.M. Bass, B.A. Neuschwander-Tetri, J.E. Lavine, J. Tonascia, A. Unalp, M. Van Natta, J. Clark, E.M. Brunt, D.E. Kleiner, J.H. Hoofnagle, P.R. Robuck, Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1675–1685 (2010)

    Article  PubMed  CAS  Google Scholar 

  10. G. Mazziotti, Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol. Metab. 22(12), 499–506 (2011)

    Article  PubMed  CAS  Google Scholar 

  11. S.H. Sheth, The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials. BMC Infect. Dis. 10, 183 (2010)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rafael Mejía-Alvarez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Winkel, E., Sabin, A. & Mejía-Alvarez, R. Cushingoid lipodystrophy can be prevented by thiazolidinediones. Endocrine 42, 746–748 (2012). https://doi.org/10.1007/s12020-012-9742-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-012-9742-8

Keywords

Navigation